Initial phase III AIDSVAX results do not reach primary end point.
D016915:AIDS Vaccines / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D008297:Male
D016915:AIDS Vaccines; C112734:AIDSVAX